Status:
COMPLETED
SCREENING AND SEROEPIDEMIOLOGY OF SARS-CoV-2 INFECTION AT THE UNIVERSITY OF BARCELONA: A CROSS-SECTIONAL STUDY
Lead Sponsor:
Dr. Francisco Ciruela Alférez
Collaborating Sponsors:
Gerencia Territorial del Área Metropolitana Sur - Instituto Catalán de la Salud
Hospital Universitario de Bellvitge
Conditions:
SARS-CoV-2 Infection
Eligibility:
All Genders
18+ years
Brief Summary
BACKGROUND: On January 7, 2020, the Chinese authorities identified as the agent responsible for the cases of atypical pneumonia of unknown etiology a new type of virus of the Coronaviridae family that...
Detailed Description
BACKGROUND: On January 7, 2020, the Chinese authorities identified as the agent responsible for the cases of atypical pneumonia of unknown etiology a new type of virus of the Coronaviridae family that...
Eligibility Criteria
Inclusion
- Adult population (18 years or more), of both sexes.
- Person linked (with identification card) to the University of Barcelona.
- Acceptance to participate in the study.
Exclusion
- There are no exclusion criteria.
Key Trial Info
Start Date :
December 14 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 24 2021
Estimated Enrollment :
3356 Patients enrolled
Trial Details
Trial ID
NCT04784403
Start Date
December 14 2020
End Date
February 24 2021
Last Update
March 5 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Francisco Ciruela Alférez
L'Hospitalet de Llobregat, Barcelona, Spain, 08907